[NEWS RELEASE Skystar Bio-Pharmaceutical Reports Second Quarter 2011 Results $9.1 Million Top Line; $0.21 Diluted EPS; Expanded Direct Distribution and Sales Channels XI’AN, CHINA – August 23, 2011 -- - Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ("Skystar" or the "Company"), Second Quarter 2011 Highlights · Revenue increases 10% YoY to $9.1 million · Veterinary vaccines totaled $0.4million, up 1.2% YoY · Veterinary]
[NEWS RELEASE Skystar Bio-Pharmaceutical Reports Second Quarter 2011 Results $9.1 Million Top Line; $0.21 Diluted EPS; Expanded Direct Distribution and Sales Channels XI’AN, CHINA – August 23, 2011 -- - Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ("Skystar" or the "Company"), Second Quarter 2011 Highlights · Revenue increases 10% YoY to $9.1 million · Veterinary vaccines totaled $0.4million, up 1.2% YoY · Veterinary]
[FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported): August 23, 2011 (August 19, 2011) EVER-GLORY INTERNATIONAL GROUP, INC. Florida 000-28806 65-0420146 (State or other jurisdiction of incorporation or organization) (Commission File No.) (IRS Employee Identification No.) Ever-Glory Commercial Center, 509 Chengxin Road, Jiangning Development Zone, Nanjing, Jiangsu Province, Peoples Republic of China (8625) 5209-6875 (Issuer Telephone]
[FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported): August 23, 2011 (August 19, 2011) EVER-GLORY INTERNATIONAL GROUP, INC. Florida 000-28806 65-0420146 (State or other jurisdiction of incorporation or organization) (Commission File No.) (IRS Employee Identification No.) Ever-Glory Commercial Center, 509 Chengxin Road, Jiangning Development Zone, Nanjing, Jiangsu Province, Peoples Republic of China (8625) 5209-6875 (Issuer Telephone]
[CUSIP No. G210821050 Page 2 of 8 1 NAMES OF REPORTING PERSONS 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) o (a) o (b) 3 SEC USE ONLY 4]
[Perfect World Co., Ltd. Kelvin Wing Kee Lau Chief Financial Officer 2 Page]
[NEWS RELEASEystar Bio-Pharmaceutical Reports Second Quarter 2011 Results $9.1 Million Top Line; $0.21 Diluted EPS; Expanded Direct Distribution andles Channels XIAN, CHINA August 23, 2011 -- -ystar Bio-Pharmaceuticalmpany (NASDAQ:SKBI) ("Skystar" or the "Company"), Second Quarter 2011 Highlights Revenuereases 10% YoY to $9.1 million Veterinary vaccines totaled $0.4million, up 1.2% YoY]
[Ku6 Media Reports Unaudited Financial Results for Second Quarter of Fiscal Year 2011 BEIJING, China, August 23, 2011/Xinhua-PRNewswire/ Ku6 Media Co., Ltd., (Ku6 Media or the Company, Nasdaq: KUTV) a leading internet television company in China, today announced its unaudited financial results for the second quarter ended June 30 of fiscal year 2011. Background In 2010, Ku6 Media (formerly]
[NEWS RELEASEystar Bio-Pharmaceutical Reports Second Quarter 2011 Results $9.1 Million Top Line; $0.21 Diluted EPS; Expanded Direct Distribution andles Channels XIAN, CHINA August 23, 2011 -- -ystar Bio-Pharmaceuticalmpany (NASDAQ:SKBI) ("Skystar" or the "Company"), Second Quarter 2011 Highlights Revenuereases 10% YoY to $9.1 million Veterinary vaccines totaled $0.4million, up 1.2% YoY]
[Ku6 Media Reports Unaudited Financial Results for Second Quarter of Fiscal Year 2011 BEIJING, China, August 23, 2011/Xinhua-PRNewswire/ Ku6 Media Co., Ltd., (Ku6 Media or the Company, Nasdaq: KUTV) a leading internet television company in China, today announced its unaudited financial results for the second quarter ended June 30 of fiscal year 2011. Background In 2010, Ku6 Media (formerly]
